Pellevé™ receives FDA clearance
for the treatment of mild to moderate facial wrinkles
Ellman International launches next-generation aesthetic skin tightening technology
OCEANSIDE, N.Y., May 18, 2009 – Ellman International, Inc. announced today that the Food and Drug Administration (FDA) has granted clearance to Pellevé™, a skin tightening system for the non-ablative treatment of mild to moderate facial wrinkles and rhytids for skin phototypes I-IV. The clearance was granted based on clinical data demonstrating that a single treatment with the high frequency radiowave device can safely and effectively tighten and improve the appearance of skin on the face through six months.
"Today’s FDA clearance of the Pellevé™ system represents a very exciting step in the introduction of next-generation high frequency radiowave technology to physicians and patients in the United States," said Rick Epstein, CEO of Ellman International, Inc. “Pellevé™ offers safe, non-invasive facial rejuvenation with no need for a local anesthetic and minimal discomfort—a significant evolution from previous-generation technologies in this class.”
About Ellman International
Established in 1959, Ellman International (Oceanside, New York) is a privately held manufacturer of medical devices used to perform a variety of surgical procedures principally requiring cutting, coagulating, tissue ablation and vaporization. The company’s products are based on patented and proprietary technologies utilizing high frequency radiowaves to perform traditional scalpel, scissor, electrosurgery and laser procedures. For more information, please visit www.ellman.com.
For additional information, contact:
Thomas Harper
Executive Vice President
Global Marketing
Ellman International
516-267-6767
tharper@ellman.com
Need Adobe Acrobat Reader?
If you do not have a copy of Acrobat Reader, you can get one for free by clicking the 'Get Acrobat® Reader' icon.
This will take you to Adobe's website and enable you to download the Acrobat program to your computer.
